1. Home
  2. Research
  3. Research Groups
  4. Neurodegenerative diseases: therapy development

Neurodegenerative diseases: therapy development

Search for publications

Only original articles, editorials, guidelines.

  • Pazos MR, Tolón RM, Benito C, Rodríguez CF, Gorgojo JJ, Nevado M, Alvarez M, Arias F, Almodóvar F, Fernández MT, Lledó JL, González S, Fernández-Ruiz JJ, Romero J.

    Cannabinoid CB1 receptors are expressed by parietal cells of the human gastric mucosa

    JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY . 56(5): 511-516. Number of citations: 19

    [doi:10.1369/jhc.2008.950741]

  • Fernández-Ruiz J, Pazos MR, García-Arencibia M, Sagredo O, Ramos JA.

    Role of CB2 receptors in neuroprotective effects of cannabinoids

    MOLECULAR AND CELLULAR ENDOCRINOLOGY . 286(1-2, 1): 91-96. Number of citations: 89

    [doi:10.1016/j.mce.2008.01.001]

  • Sagredo O, García-Arencibia M, de Lago E, Finetti S, Decio A, Fernández-Ruiz J.

    Cannabinoids and neuroprotection in basal ganglia disorders

    MOLECULAR NEUROBIOLOGY . 36(1): 82-91. Number of citations: 71

    [doi:10.1007/s12035-007-0004-3]

  • García-Arencibia M, González S, de Lago E, Ramos JA, Mechoulam R, Fernández-Ruiz J.

    Evaluation of the neuroprotective effect of cannabinoids in a rat model of Parkinson's disease: Importance of antioxidant and cannabinoid receptor-independent properties

    BRAIN RESEARCH . 1134(1): 162-170. Number of citations: 206

    [doi:10.1016/j.brainres.2006.11.063]

  • GÓMEZ CAÑAS, MARÍA, FERNÁNDEZ RUIZ, JOSÉ JAVIER.

    Synthesis and pharmacological evaluation of new (E)- and (Z)-3-aryl-4-styryl-1H-pyrazoles as potential cannabinoid ligands

    Arkivoc . 2010: 226-247.

    [doi:10.3998/ark.5550190.0011.a19]